Show/hide main menu

Publications 2018

Addictions CAG Publications 2018 May to Dec

Agrawal A. Chou Y.L. Carey C.E. Baranger D.A.A. Zhang B. Sherva R. Wetherill L. Kapoor M. Wang J.C. Bertelsen S. Anokhin A.P. Hesselbrock V. Kramer J. Lynskey M.T. Meyers J.L. Nurnberger J.I. Rice J.P. Tischfield J. Bierut L.J. Degenhardt L. Farrer L.A. Gelernter J. Hariri A.R. Heath A.C. Kranzler H.R. Madden P.A.F. Martin N.G. Montgomery G.W. Porjesz B. Wang T. Whitfield J.B. Edenberg H.J. Foroud T. Goate A.M. Bogdan R. Nelson E.C. (2018). Genome-wide association study identifies a novel locus for cannabis dependence. Molecular Psychiatry. 23(5):1293-1302. doi: 10.1038/mp.2017.200.


Alla K. Oprescu F. Hall W.D. Whiteford H.A. Head B.W. Meurk C.S. (2018). Can automated content analysis be used to assess and improve the use of evidence in mental health policy? A systematic review. Systematic Reviews. 7(1):194. doi: 10.1186/s13643-018-0853-z.


Barnett A. Hall W. Fry C.L. Dilkes-Frayne E. Carter A. (2018). Implications of treatment providers' varying conceptions of the disease model of addiction: A response. Drug and Alcohol Review. doi: 10.1111/dar.12844. [Epub ahead of print].


Bloomfield M.A.P. Hindocha C. Green S.F. Wall M.B. Lees R. Petrilli K. Costello H. Ogunbiyi M.O. Bossong M.G. Freeman T.P. (2018). The neuropsychopharmacology of cannabis: A review of human imaging studies. Pharmacology and Therapeutics. doi: 10.1016/j.pharmthera.2018.10.006. [Epub ahead of print].


Boniface S. (2018). Commentary on Bhattacharya et al. (2018). Reliance of the alcohol industry on heavy drinkers makes case against industry involvement in alcohol policy. Addiction. 113(12):2233-2234. doi: 10.1111/add.14420.


Branston J.R. McNeill A. Gilmore A.B. Hiscock R. Partos T.R. (2018). Keeping smoking affordable in higher tax environments via smoking thinner roll-your-own cigarettes: Findings from the International Tobacco Control Four Country Survey 2006-15. Drug and Alcohol Dependence. 193:110-116. doi: 10.1016/j.drugalcdep.2018.07.047.


Brose L. (2018). Weak tobacco control policy. Deutsches Ärzteblatt International. 115(27-28):478. doi: 10.3238/arztebl.2018.0478b.


Brose L.S. Simonavicius E. McNeill A. (2018). Rejoinder relating to correspondence by Dr Eleanor Woodward, Professor Robyn Richmond on Brose LS, Simonavicius E, McNeill A (2018). Maintaining abstinence from smoking after a period of enforced abstinence. Psychological Medicine. doi: 10.1017/S0033291718003410. [Epub ahead of print].


Bruno R. Edirisinghe M. Hall W. Mueller J.F. Lai F.Y. O'Brien J.W. Thai P.K. (2018). Association between purity of drug seizures and illicit drug loads measured in wastewater in a South East Queensland catchment over a six year period. Science of the Total Environment. 635:779-783. doi: 10.1016/j.scitotenv.2018.04.192.


Butterworth P. Becker D. Degenhardt L. Hall W.D. Patton G.C. (2018). Amphetamine use in the fourth decade of life: social profiles from a population-based Australian cohort. Drug and Alcohol Review. 37(6):743-751. doi: 10.1111/dar.12840.


Campbell G. Hall W.D. Peacock A. Lintzeris N. Bruno R. Larance B. Nielsen S. Cohen M. Chan G. Mattick R.P. Blyth F. Shanahan M. Dobbins T. Farrell M. Degenhardt L. (2018). Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health. 3(7):e341-e350. doi: 10.1016/S2468-2667(18)30110-5.


Chan G.C.K. Butterworth P. Becker D. Degenhardt L. Stockings E. Hall W. Patton G. (2018). Longitudinal patterns of amphetamine use from adolescence to adulthood: A latent class analysis of a 20-year prospective study of Australians. Drug and Alcohol Dependence. 194:121-127. doi: 10.1016/j.drugalcdep.2018.08.042.


Chan G.C.K. Leung J. Kelly A.B. Connor J. Edward S. Hall W. Degenhardt L. Chiu V. Patton G. (2018). Familial alcohol supply, adolescent drinking and early alcohol onset in 45 low and middle income countries. Addictive Behaviors. 84:178-185. doi: 10.1016/j.addbeh.2018.04.014.


Chyderiotis S. Beck F. Andler R. Hitchman S.C. Benmarhnia T. (2018). How to reduce biases coming from a before and after design: the impact of the 2007-08 French smoking ban policy. European Journal of Public Health.  doi: 10.1093/eurpub/cky160. [Epub ahead of print].


Curran H.V. Hindocha C. Morgan C.J.A. Shaban N. Das R.K. Freeman T.P. (2018). Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects? Psychological Medicine.  doi: 10.1017/S003329171800226X. [Epub ahead of print].


Davis C.N. Slutske W.S. Martin N.G. Agrawal A. Lynskey M.T. (2018). Genetic and environmental influences on gambling disorder liability: a replication and combined analysis of two twin studies. Psychological Medicine.  doi: 10.1017/S0033291718002325. [Epub ahead of print].


Day E. Copello A. Seddon J.L. Christie M. Bamber D. Powell C. Bennett C. Akhtar S. George S. Ball A. Frew E. Goranitis I. Freemantle N. (2018). A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services. BMC Psychiatry. 18(1):8. doi: 10.1186/s12888-018-1600-7.


Dorrington S. Roberts E. Mykletun A. Hatch S. Madan I. Hotopf M. (2018). Systematic review of fit note use for workers in the UK. Occupational and Environmental Medicine. 75(7):530-539. doi: 10.1136/oemed-2017-104730. 


East K. Brose L.S. McNeill A. Cheeseman H. Arnott D. Hitchman S.C. (2018). Harm perceptions of electronic cigarettes and nicotine: A nationally representative cross-sectional survey of young people in Great Britain. Drug and Alcohol Dependence. 192:257-263. doi: 10.1016/j.drugalcdep.2018.08.016.


East K. Hitchman S.C. Bakolis I. Williams S. Cheeseman H. Arnott D. McNeill A. (2018). The association between smoking and electronic cigarette use in a cohort of young people. Journal of Adolescent Health. 62(5):539-547. doi: 10.1016/j.jadohealth.2017.11.301.


East K. Hitchman S.C. Bakolis I. Williams S. Cheeseman H. Arnott D. McNeill A. (2018). The authors reply. Journal of Adolescent Health. 63(1):118-119. doi: 10.1016/j.jadohealth.2018.04.006.


Eastwood B. Strang J. Marsden J. (2018). Change in alcohol and other drug use during five years of continuous opioid substitution treatment. Drug and Alcohol Dependence. 194:438-446. i: 10.1016/j.drugalcdep.2018.11.008


Farrugia A. Fraser S. Dwyer R. Renae F. Neale J. Dietze P.  Strang J. S. (2018). Take-home naloxone and the politics of care (2018). Sociology of Health and Illness. (Accepted/In press).


Fincham-Campbell S. Kimergård A. Wolstenholme A. Blackwood R. Patton R. Dunne J. Deluca P. Drummond C. (2018). A national survey of assertive outreach  treatment services for people who frequently attend hospital due to alcohol-related reasons in England. Alcohol and Alcoholism. 53(3):277-281. doi: 10.1093/alcalc/agx095.


Foley M. Peter K. Deluca P. Kimergård A. (2018). Advertising of over-the-counter codeine-containing medicines in the EU: Differences in the regulation of advertising between Member States. Pharmaceutical Medicine. 32:327–333.


Freeman T. P. Wilson J. Mackie C. (2018). Commentary on Salloum et al. (2018): Rethinking adolescent cannabis use and risk perception. Addiction. 113(6):1086-1087. doi: 10.1111/add.14212.


Freeman T.P. Mehta M.A. Neill J.C. Nutt D.J. Tunbridge E.M. Young A.H. (2018). Restrictions on drugs with medical value: Moving beyond stalemate. Journal of Psychopharmacology. 32(10):1053-1055. doi: 10.1177/0269881118798609.


Grebely J. Larney S. Peacock A. Colledge S. Leung J. Hickman M. Vickerman P. Blach S. Cunningham E.B. Dumchev K. Lynskey M. Stone J. Trickey A. Razavi H. Mattick R.P. Farrell M. Dore G.J. Degenhardt L. (2018). Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction. doi: 10.1111/add.14393. [Epub ahead of print].


Hall W. (2018).Imperfect international treaties interpreted flexibly are likely to be better than no treaties. Addiction. 113(7):1230. doi: 10.1111/add.14218.


Hall W. Parker M. (2018). Reasons for ambivalence about accepting addiction as a reason for performing euthanasia. Addiction. 113(7):1186-1187. doi: 10.1111/add.14246.


Hall W. West R. Marsden J. Humphreys K. Neale J.O. Petry N. (2018). The need for more consistent evidential standards in cannabis policy evaluations. Addiction. 113(8):1553-1554. doi: 10.1111/add.14262.


Hall W.D. Farrell M. (2018). Reducing the opioid overdose death toll in North America. PLoS Medicine. 15(7):e1002626. doi: 10.1371/journal.pmed.1002626.


Harris M. Brathwaite R. Scott J. Gilchrist G. Ciccarone D. Hope V. McGowan C.R. (2018). Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugs. Addiction. 113(10):1790-1801. doi: 10.1111/add.14257.


Harris M. Brathwaite R. McGowan C.R. Ciccarone D. Gilchrist G. McCusker M. O'Brien K. Dunn J. Scott J. Hope V. (2018). 'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London. Harm Reduction Journal. 15(1):23. doi: 10.1186/s12954-018-0233-y.


Healey A. Roberts S. Sevdalis N. Goulding L. Wilson S. Shaw K. Jolley C. Robson D. (2018). A cost-effectiveness analysis of Stop Smoking interventions in Substance Use Disorder populations undergoing treatment. Nicotine and Tobacco Research.  doi: 10.1093/ntr/nty087. [Epub ahead of print].


Hickling L. M. Perez-Iglesias R. McNeill A. Dawkins L. Moxham J. Ruffell T. O. Sendt K-V. McGuire P. (2018). A pre-post pilot study of electronic cigarettes to reduce smoking in people with severe mental illness. Psychological Medicine. doi: 10.1017/S0033291718001782. [Epub ahead of print].


Hickling L. M. Perez-Iglesias R. McNeill A. Dawkins L. Moxham J. Ruffell T. O. Sendt K-V. McGuire P. (2018). Corrigendum to 'A pre-post pilot study of electronic cigarettes to reduce smoking in people with severe mental illness'. Psychological Medicine. doi: 10.1017/S0033291718003100. [Epub ahead of print].


Hickman M. Steer C. Tilling K. Lim A.G. Marsden J. Millar T. Strang J. Telfer M. Vickerman P. Macleod J. (2018). The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. Addiction. 13(8):1461-1476. doi: 10.1111/add.14188.


Hindocha C. Freeman T.P. Grabski M. Crudgington H. Davies A.C. Stroud J.B. Das R.K. Lawn W. Morgan C.J.A. Curran H.V. The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers. Scientific  Reports. 8(1):7568. doi: 10.1038/s41598-018-25846-2.


Hindocha C. Freeman T.P. Grabski M. Stroud J.B. Crudgington H. Davies A.C. Das R.K. Lawn W. Morgan C.J.A. Curran H.V. (2018). Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal.Addiction. doi: 10.1111/add.14243. [Epub ahead of print].


Hines L. A. Strang J. S. Morley K. I.  Lynskey M. T. (2018). Characterising opportunity to use heroin reveals new avenues for intervention: Context, outcomes, and latency to initiation. Drugs: Education, Prevention and Policy. (Accepted/In press).


Hobbs M. Kalk N.J. Morrison P.D. Stone J.M. (2018). Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review. European Neuropsychopharmacology. doi: 10.1016/j.euroneuro.2018.10.004. [Epub ahead of print].


Kahnert S. Demjén T. Tountas Y. Trofor A. Przewoźniak K. Zatónski W. A. Fernández E. McNeill A. D. Willemsen M. Kyriakos C. N. Fong G. T. Vardavas C.  Mons U. (2018). Extent and correlates of self-reported exposure to tobacco advertising, promotion, and sponsorship in smokers: Findings from the EUREST -PLUS ITC Europe Surveys Tobacco marketing exposure – findings from ITC Europe.  Tobacco Induced Diseases.(Accepted/In press).


Kalk N.J. (2018). Harm reduction in opioid treatment: an established idea under threat. Addiction.  doi: 10.1111/add.14468. [Epub ahead of print].


Kalk N.J. Kelleher M.J. Curtis V. Morley K.I. (2018). Addressing substance misuse: a missed opportunity in suicide prevention. Addiction. doi: 10.1111/add.14463. [Epub ahead of print].


Karcher N.R. Barch D.M. Demers C.H. Baranger D.A.A. Heath A.C. Lynskey M.T. Agrawal A. (2018). Genetic predisposition vs individual-specific processes in the association between psychotic-like experiences and cannabis use. JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2018.2546. [Epub ahead of print].


Kravariti E. Demjaha A. Zanelli J. Ibrahim F. Wise C. MacCabe J.H. Reichenberg A. Pilecka I. Morgan K. Fearon P. Morgan C. Doody G.A. Donoghue K. Jones P.B. Kaçar A.Ş. Dazzan P. Lappin J. Murray R.M. (2018). Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study. Psychological Medicine. doi: 10.1017/S0033291718002957. [Epub ahead of print].


Larance B. Campbell G. Moore T. Nielsen S. Bruno R. Lintzeris N. Cohen M. Hall W. Mattick R. O'Donnell C. Degenhardt L. (2018). Concerns and help-seeking among patients using opioids for management of chronic noncancer pain. Pain Medicine. doi: 10.1093/pm/pny078. [Epub ahead of print].


Leightley D. Puddephatt J.A. Jones N. Mahmoodi T. Chui Z. Field M. Drummond C. Rona R.J. Fear N.T. Goodwin L. (2018). A smartphone app and personalized text messaging framework (InDEx) to monitor and reduce alcohol use in ex-serving personnel: Development and feasibility study. JMIR Mhealth Uhealth. 6(9):e10074. doi: 10.2196/10074.


Lucke J. Jensen C. Dunn M. Chan G. Forlini C. Kaye S. Partridge B. Farrell M. Racine E. Hall W. (2018). Non-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use. BMC Public Health. 18(1):1270. doi: 10.1186/s12889-018-6212-0.


Madden A. Hopwood M. Neale J. Treloar C. (2018). Acceptability of patient-reported outcome and experience measures for hepatitis C treatment among people who use drugs. Patient. doi: 10.1007/s40271-018-0332-6. [Epub ahead of print].


Madden A. Hopwood M. Neale J. Treloar C. (2018). Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia. Harm Reduction Journal. 15(1):42. doi: 10.1186/s12954-018-0248-4.


Matcham F. Galloway J. Hotopf M. Roberts E. Scott I.C. Steer S. Norton S. (2018). The impact of targeted rheumatoid arthritis pharmacologic treatment on mental health: A systematic review and network meta-analysis. Arthritis and Rheumatology. 70(9):1377-1391. doi: 10.1002/art.40565.


McGeechan G.J. Giles E.L. Scott S. McGovern R. Boniface S. Ramsay A. Sumnall H. Newbury-Birch D. Kaner E. SIPS JR-HIGH Study Team. (2018). A qualitative exploration of school-based staff's experiences of delivering an alcohol screening and brief intervention in the high school setting: findings from the SIPS JR-HIGH trial. Journal of Public Health. doi: 10.1093/pubmed/fdy184. [Epub ahead of print].


Metrebian N. Weaver T. Pilling S. Hellier J. Byford S. Shearer J. Mitcheson L. Astbury M. Bijral P. Bogdan N. Bowden-Jones O. Day E. Dunn J. Finch E. Forshall S. Glasper A. Morse G. Akhtar S. Bajaria J. Bennett C. Bishop E. Charles V. Davey C. Desai R. Goodfellow C. Haque F. Little N. McKechnie H. Morris J. Mosler F. Mutz J. Pauli R. Poovendran D. Slater E. Strang J. (2018). Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management. Contemporary Clinical Trials. 71:124-132. doi: 10.1016/j.cct.2018.06.008.


Middleton A.  Niemiec E.  Prainsack B.  Bobe J.  Farley L.  Steed C. Smith J.  Bevan P.  Bonhomme N.  Kleiderman E.  Thorogood A.  Schickhardt C.  Garattini C.  Vears D.  Littler, K.  Banner N.  Scott E.  Kovalevskaya N. V.  Levin E.  Morley K. I. Howard H.C. (2018). 'Your DNA, Your Say': global survey gathering attitudes toward genomics: design, delivery and methods. Howard, H. C. Personalized Medicine. 15(4):311-318. doi: 10.2217/pme-2018-0032.


Milward J. Drummond C. Fincham-Campbell S. Deluca P. (2018). What makes online substance-use interventions engaging? A systematic review and narrative synthesis. Digital Health. 2018 4:2055207617743354. doi: 10.1177/2055207617743354.


Moodie C. MacKintosh A.M. Thrasher J.F. McNeill A. Hitchman S. (2018). Use of cigarettes with flavour-changing capsules among smokers in the United Kingdom: An online survey. Nicotine and Tobacco Research. doi: 10.1093/ntr/nty173. [Epub ahead of print].


Morgan C.J.A. Freeman T.P. Hindocha C. Schafer G. Gardner C. Curran H.V. (2018). Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Translational  Psychiatry. 8(1):181. doi: 10.1038/s41398-018-0191-x.


Neale J. Parkman T. J.  Strang J. S. (2018). Challenges in delivering personalised support to people with multiple and complex needs: qualitative study. Journal of Interprofessional Care. doi: 10.1080/13561820.2018.1553869. [Epub ahead of print].


Neale J. Tompkins C. N. E. McDonald R. Strang J. (2018). Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin. Drug and Alcohol Dependence. 189:1-7. doi: 10.1016/j.drugalcdep.2018.03.057.


Neale J. Tompkins C.N.E. McDonald R. Strang J. (2018). Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making. Experimental and Clinical Psychopharmacology. doi: 10.1037/pha0000217. [Epub ahead of print].


Neale J. Tompkins C.N.E. Marshall A.D. Treloar C. Strang J. (2018). Building on feminist achievements to enhance choice for women seeking treatment. Addiction. 113(6):1001-1002. doi: 10.1111/add.14226.


Neale J. Brown C. Campbell A. Jones J. Metz V. Strang J. S. Comer S. D. (2018). How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken by lay first-responders during overdose emergencies. Addiction. doi: 10.1111/add.14510.


Partos T.R. Branston J.R. Hiscock R. Gilmore A.B. McNeill A. (2018). Individualised tobacco affordability in the UK 2002-2014: findings from the International Tobacco Control Policy Evaluation Project. Tobacco Control.  doi: 10.1136/tobaccocontrol-2017-054027. [Epub ahead of print].


Peak J. Goranitis I. Day E. Copello A. Freemantle N. Frew E. (2018). Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP. Health and Quality of Life Outcomes.16(1):106. doi: 10.1186/s12955-018-0926-7.


Reed K. Knight, A. Baillie S. Bell J. R.  Strang J. S.(2018). Switching between lyophilized and sub-lingual buprenorphine formulations in opioid-dependent patients: Observations on medication transfer during a safety and pharmacokinetic study. Heroin Addiction and Related Clinical Problems. 20(5):19-28.


Richardson S. McNeill A. Brose LS. (2018). Smoking and quitting behaviours by mental health conditions in Great Britain (1993-2014). Addictive Behaviors. 90:14-19. doi: 10.1016/j.addbeh.2018.10.011.


Richmond-Rakerd L.S. Trull T.J. Gizer I.R. McLaughlin K. Scheiderer E.M. Nelson E.C. Agrawal A. Lynskey M.T. Madden P.A.F. Heath A.C. Statham D.J. Martin N.G. (2018). Common genetic contributions to high-risk trauma exposure and self-injurious thoughts and behaviors. Psychological Medicine.  doi: 10.1017/S0033291718001034. [Epub ahead of print].


Roberts E. Carter B. Young A. H. (2018). Caveat emptor: Folate in unipolar depressive illness, a systematic review and meta-analysis. Journal of Psychopharmacology. 32(4):377-384. doi: 10.1177/0269881118756060.


Robertson R. McAuley A. Macleod J. Strang J. McCallum A. (2018). Drugs policy will not change as long as UK government refuses to acknowledge the need for change. British Medical Journal. 361:k2604. doi: 10.1136/bmj.k2604.


Simonavicius E. McNeill A. Shahab L. Brose L.S. (2018). Heat-not-burn tobacco products: a systematic literature review. Tobacco Control.  doi: 10.1136/tobaccocontrol-2018-054419. [Epub ahead of print].


Stockings E. Campbell G. Hall W.D. Nielsen S. Zagic D. Rahman R. Murnion B. Farrell M. Weier M. Degenhardt L. (2018). Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. doi: 10.1097/j.pain.0000000000001293. [Epub ahead of print].


Thirlway F. Bauld L. McNeill A. Notley C. (2018). Tobacco smoking and vulnerable groups: Overcoming the barriers to harm reduction. Addictive Behaviors. 90:134-135. doi: 10.1016/j.addbeh.2018.10.016.


Tien Y.M. Chen V.C. Lo T.S. Hsu C.F. Gossop M. Huang K.Y. (2018). Deficits in auditory sensory discrimination among children with attention-deficit/hyperactivity disorder. European Child and Adolescent Psychiatry.  doi: 10.1007/s00787-018-1228-7. [Epub ahead of print].


Tompkins C.N.E. Parkman T. Pothecary J.C. (2018). Implementing and delivering personalised budgets for drug and alcohol users: A narrative systematic review. Health and Social Care in the Community. doi: 10.1111/hsc.12633. [Epub ahead of print].


Velupillai S. Suominen H. Liakata M. Roberts A. Shah A.D. Morley K. Osborn D. Hayes J. Stewart R. Downs J. Chapman W. Dutta R. (2018). Using clinical natural language processing for health outcomes research: Overview and actionable suggestions for future advances. Journal of Biomedical Informatics.  doi: 10.1016/j.jbi.2018.10.005. [Epub ahead of print].


Walters R.K. Polimanti R. Johnson E.C. McClintick J.N. Lynskey M.T. Agrawal A. (2018). Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nature Neuroscience. 21(12):1656-1669. doi: 10.1038/s41593-018-0275-1.


Webster S. Robinson S. Ali R. Marsden J. (2018). Improving outcomes in the treatment of opioid dependence (IOTOD): reflections on the impact of a medical education initiative on healthcare professionals' attitudes and clinical practice. Journal of European CME. 7(1):1506197. doi: 10.1080/21614083.2018.1506197.


West R. Marsden J. Humphreys K. Darke S. (2018). A revised checklist for writing up research reports. Addiction. 113(9): 1567-1570. doi: 10.1111/add.14269.


Williams R. Alexander G. Aspinall R. Drummond C. Yeoman A. (2018). Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK. Lancet. 392(10162):2398-2412. doi: 10.1016/S0140-6736(18)32561-3.


Yong H.H. Borland R. Hitchman S.C. Cummings K.M. Gravely S.M.L. McNeill A. Fong G.T. (2018). Response to Letter to the Editor by Benmarhnia T, Leas E, Hendrickson E, Trinidad D, Strong D, Pierce J. The potential influence of regulatory environment for e-cigarettes on the effectiveness of e-cigarettes for smoking cessation: Different reasons to temper the conclusions from inadequate data. Nicotine and Tobacco Research. 20(5):660-661. doi: 10.1093/ntr/ntx127.



(As of 14th Dec 2018)

Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454